SET and MYND domain-containing protein 3 (SMYD3) expression was elevated in VHL-defective RCC and cooperation between SMYD3 and SP1 increased EGFR expression and enhanced down-signals of EGFR [46]. Here, SMYD3 is linked to renal cell carcinoma.